Harvey M. Golomb to Prognosis
This is a "connection" page, showing publications Harvey M. Golomb has written about Prognosis.
Connection Strength
0.201
-
Hairy cell leukaemia. Baillieres Clin Haematol. 1993 Dec; 6(4):887-98.
Score: 0.017
-
Sex-associated differences in presentation and survival in patients with lung cancer. J Clin Oncol. 1990 Aug; 8(8):1402-7.
Score: 0.014
-
Hairy cell leukemia. Current management. Hematol Oncol Clin North Am. 1990 Apr; 4(2):489-502.
Score: 0.013
-
Prognostic variables in hairy cell leukemia after splenectomy as initial therapy. Cancer. 1988 Dec 01; 62(11):2420-4.
Score: 0.012
-
Specific chromosomal abnormalities in acute nonlymphocytic leukemia correlate with drug susceptibility in vivo. Leukemia. 1988 Feb; 2(2):79-83.
Score: 0.011
-
A 10-year experience with combined modality therapy for stage III small cell lung carcinoma. Cancer. 1986 Nov 15; 58(10):2177-84.
Score: 0.010
-
Prognostic significance of immunologic phenotype in hairy cell leukemia: does it exist? Blood. 1985 Dec; 66(6):1358-61.
Score: 0.010
-
Hairy cell leukemia: a five-year update on seventy-one patients. Ann Intern Med. 1983 Oct; 99(4):485-6.
Score: 0.008
-
Non-small cell carcinoma of the lung. Semin Oncol. 1983 Mar; 10(1):1-122.
Score: 0.008
-
Chemotherapy of metastatic non-small cell bronchogenic carcinoma. Semin Oncol. 1983 Mar; 10(1):111-22.
Score: 0.008
-
Significance of cytogenetic abnormalities in acute leukemias. Hum Pathol. 1981 Jun; 12(6):515-22.
Score: 0.007
-
Importance of substaging of stage III Hodgkin's disease. Semin Oncol. 1980 Jun; 7(2):136-43.
Score: 0.007
-
Small-cell carcinoma of the lung: the prognostic significance of stage on survival. Eur J Cancer (1965). 1979 Jun; 15(6):859-65.
Score: 0.006
-
Clinical implications of chromosome abnormalities in acute non-lymphocytic leukemia: current status. Virchows Arch B Cell Pathol. 1978 Nov 17; 29(1-2):73-9.
Score: 0.006
-
Hairy cell leukemia: a clinical review based on 71 cases. Ann Intern Med. 1978 Nov; 89(5 Pt 1):677-83.
Score: 0.006
-
Chromosome abnormalities in patients with hairy cell leukemia. Cancer. 1978 Apr; 41(4):1374-80.
Score: 0.006
-
Radiation therapy for pathologic stage III Hodgkin's disease with and without chemotherapy. Int J Radiat Oncol Biol Phys. 1989 Oct; 17(4):761-6.
Score: 0.003
-
Six-year follow-up of the clinical significance of karyotype in acute lymphoblastic leukemia. Cancer Genet Cytogenet. 1989 Jul 15; 40(2):171-85.
Score: 0.003
-
The clinical significance of karyotype in acute myelogenous leukemia. Cancer Genet Cytogenet. 1989 Jul 15; 40(2):203-16.
Score: 0.003
-
Cost-benefit analysis of interferon alfa-2b in treatment of hairy cell leukemia. J Natl Cancer Inst. 1989 Apr 19; 81(8):594-602.
Score: 0.003
-
Relapse after interferon alfa-2b therapy for hairy-cell leukemia: analysis of prognostic variables. J Clin Oncol. 1988 Nov; 6(11):1714-21.
Score: 0.003
-
Adenosquamous lung carcinoma: clinical characteristics, treatment, and prognosis. Ann Thorac Surg. 1987 Nov; 44(5):462-6.
Score: 0.003
-
Treatment of diffuse histiocytic lymphoma (DHL) with COMLA (cyclophosphamide, oncovin, methotrexate, leucovorin, cytosine arabinoside): a 10-year experience in a single institution. J Clin Oncol. 1985 Dec; 3(12):1596-604.
Score: 0.002
-
Large cell carcinoma of the lung. Ultrastructural differentiation and clinicopathologic correlations. Cancer. 1985 Oct 01; 56(7):1618-23.
Score: 0.002
-
Long-term survival of patients with localized diffuse histiocytic lymphoma. J Clin Oncol. 1985 Oct; 3(10):1309-17.
Score: 0.002
-
Combined modality therapy for Stage IIIMO non-small cell lung cancer. A five-year experience. Cancer. 1984 Jul 01; 54(1):5-12.
Score: 0.002
-
The use of serum albumin for further classification of Stage III non-oat cell lung cancer and its therapeutic implications. Ann Thorac Surg. 1984 Feb; 37(2):115-22.
Score: 0.002
-
The predictive value of initial cytogenetic studies in 148 adults with acute nonlymphocytic leukemia: a 12-year study (1970-1982). Cancer Genet Cytogenet. 1983 Nov; 10(3):219-36.
Score: 0.002
-
Treatment of modified Stage II (T1 N1 M0, T2 N1 M0) non-small cell bronchogenic carcinoma. A combined modality approach. J Thorac Cardiovasc Surg. 1983 Aug; 86(2):180-5.
Score: 0.002
-
Prognostic factors in patients with non-small cell bronchogenic carcinoma and brain metastases. Cancer. 1982 May 01; 49(9):1916-9.
Score: 0.002
-
Prognostic significance of posttransfusion hepatitis and chromosomal abnormalities in adult acute nonlymphocytic leukemia. Cancer Genet Cytogenet. 1982 Apr; 5(4):281-92.
Score: 0.002
-
Diffuse histiocytic lymphoma with sclerosis: a clinicopathologic entity frequently causing superior venacaval obstruction. Cancer. 1981 Feb 15; 47(4):748-56.
Score: 0.002
-
Prognostic significance of immunological tests in lung cancer. Clin Exp Immunol. 1981 Feb; 43(2):362-9.
Score: 0.002
-
Small-cell carcinoma of the lung: a five-year experience with combined modality therapy. Cancer. 1980 Dec 15; 46(12):2550-6.
Score: 0.002
-
Dysmyelopoietic syndrome: sequential clinical and cytogenetic studies. Blood. 1980 Apr; 55(4):636-44.
Score: 0.002
-
Anatomic substages of stage III-A Hodgkin's disease. A collaborative study. Ann Intern Med. 1980 Feb; 92(2 Pt 1):159-65.
Score: 0.002
-
Chromosomes and causation of human cancer and leukemia. XXXV. The missing Y in acute non-lymphocytic leukemia (ANLL). Cancer. 1980 Jan 01; 45(1):84-90.
Score: 0.002
-
Prognostic classification of Hodgkin disease in pathologic stage III, based on anatomic considerations. Blood. 1977 Jun; 49(6):883-93.
Score: 0.001
-
Survival of patients with localized histiocytic lymphoma. Cancer. 1977 Jan; 39(1):342-6.
Score: 0.001